Cardiovascular Disease Doctors in Grandville, MI Accepting Medicare

1 Cardiovascular Disease doctors found. Showing 1 - 1

Dr. Sandeep Khurana, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3181 Prairie St Sw, Suite 112, Grandville, MI 49418 Phone: 616-780-7015    Fax: 866-966-9677

News Archive

New educational pre-disaster video developed for child daycare providers

Children present with unique needs, particularly in a disaster. One challenge is that children may be completely dependent on adults for their care. With this in mind, and considering the physical, psychological and legal needs of children during and after a disaster, a group of stakeholders devised the outline for an educational pre-disaster video for child daycare providers in Los Angeles County using the Delphi technique.

DNA patent case: US District Judge rules in favor of AMP

The Association for Molecular Pathology (AMP) is an international medical and professional association representing approximately 1,800 physicians, doctoral scientists, and medical laboratory scientists who perform laboratory testing based on knowledge derived from molecular biology, genetics, and genomics. AMP applauds US District Judge Robert Sweet's ruling in favor of the plaintiffs in the lawsuit, Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al.

FDA categorizes Nanosphere's RVNATSP assay on Verigene SP System as "Moderate Complexity"

Nanosphere, Inc., a leader in the development and commercialization of advanced molecular diagnostics systems, received notification from the U.S. Food and Drug Administration (FDA) that its respiratory virus panel (RVNATSP) performed on the Verigene SP System has been categorized as "Moderate Complexity" under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

Labopharm settles $1 million standby equity distribution with YA Global Master SPV

Labopharm Inc. today announced it has settled the previously announced draw down of $1 million under its standby equity distribution (SEDA) with YA Global Master SPV Ltd. (YA). Under the draw down, Labopharm issued 482,165 of its common shares to YA at a price of $2.07 per common share, net of the applicable discount. (All currency figures are in Canadian dollars.)

Read more Medical News

› Verified 5 days ago